As GenomeWeb News reported in May, the acquisition would give Agilent one of the largest installed bases of chromatographic data systems -- SSI has more than 120,000 installations -- and a broad portfolio of laboratory informatics software in the life science and chemical industries.
The acquisition would enable Agilent to provide a "family" of software products that "addresses the complete life cycle of analytical information, from data acquisition to knowledge management and retention." It will also allow scientists "to collaborate across laboratory operations, linking information from a wide range of instrument platforms and data sources," Jim Miller, director of software for the Life Sciences and Chemical Analysis business, said in a statement.
"Most" of SSI's 80 employees have joined Agilent as part of the company's Life Sciences and Chemical Analysis business, Agilent said.
SSI, based in
Agilent has been the exclusive distributor of SSI's ECM since July 2004, and is currently using the technology in-house. An Agilent spokesperson said the unit expects to "expand the application" of this technology within the business group.
More broadly, Agilent said that following the acquisition it plans to "continue development and support of each of these product lines with a commitment to open systems, industry standards, and interoperability with other instrument hardware and software providers." Agilent also plans to support and enhance SSI Instrument OEM partnerships, the company said.